About chrismoorecm1gmailcom

This author has not yet filled in any details.
So far chrismoorecm1gmailcom has created 26 blog entries.

Bioarray Genetics Named Innovator of the Month

2018-08-01T21:36:39+00:00

Bioarray Genetics Named "Murphy's Innovator of the Month" WASHINGTON – U.S. Senator Chris Murphy (D-Conn.) announced on Tuesday that Bioarray Genetics, a Farmington biotech company housed at University of Connecticut’s (UConn) Technology Incubation Program (TIP), is “Murphy’s Innovator of the Month.” Bioarray Genetics focuses on using genomics and machine learning to predict the treatment [...]

Bioarray Genetics Named Innovator of the Month2018-08-01T21:36:39+00:00

2018 Entrepreneur of the Year: Scalable Venture

2018-04-25T22:56:57+00:00

2018 CT Entrepreneur of the Year: Scalable Venture April 20th, 2018 New Haven, CT It was with great honor tonight that Bioarray Genetics' CEO  Founder, Marcia Fournier, won the 2018 CT Entrepreneur of the Year Award in the Scalable Ventures category.  Nominations began in January 2018 and were judged by [...]

2018 Entrepreneur of the Year: Scalable Venture2018-04-25T22:56:57+00:00

AACR Abstract: Isolation and detection of breast cancer cells in blood samples using antibody cocktails selected by large-scale genome-wide screening

2018-04-20T05:05:25+00:00

Isolation and detection of breast cancer cells in blood samples using antibody cocktails selected by large-scale genome-wide screening Screening and prevention is critical to reducing breast cancer deaths, and mammography is not an ideal tool. To address this critical unmet need, we developed a panel of cell surface markers whose expression [...]

AACR Abstract: Isolation and detection of breast cancer cells in blood samples using antibody cocktails selected by large-scale genome-wide screening2018-04-20T05:05:25+00:00

AACR Abstract: Genes involved in non-malignant breast phenotypes are widely expressed in multiple cancers and provide novel biomarkers of clinical outcomes and therapeutic response

2018-04-20T05:06:20+00:00

Genes involved in non-malignant breast phenotypes are widely expressed in multiple cancers and provide novel biomarkers of clinical outcomes and therapeutic response We selected novel biomarkers based on non-malignant breast epithelial cell phenotypes and identified 325 genes (BA325) showing 32 significant oncology drug associations. A total of 251 genes out [...]

AACR Abstract: Genes involved in non-malignant breast phenotypes are widely expressed in multiple cancers and provide novel biomarkers of clinical outcomes and therapeutic response2018-04-20T05:06:20+00:00

Bioarray awarded patent for breast cancer treatment predictive test

2018-04-26T20:46:42+00:00

Bioarray Genetics awarded patent for breast cancer treatment predictive test Farmington-based molecular diagnostics company Bioarray Genetics Inc. has received a U.S. patent supporting its lead breast cancer predictive test. The patent covers methods and kits for predicting the effectiveness of breast cancer treatments. The method also generates a report indicating [...]

Bioarray awarded patent for breast cancer treatment predictive test2018-04-26T20:46:42+00:00

Bioarray Genetics Presents at the 40th Annual San Antonio Breast Cancer Symposium

2018-04-26T20:57:56+00:00

Bioarray Genetics Presents at the 40th Annual San Antonio Breast Cancer Symposium Bioarray Genetics announced today that the Company will be presenting a pivotal study at the upcoming 40th Annual San Antonio Breast Cancer Symposium on December 7th. Bioarray conducted a 582-patient clinical validation study that confirms the company's lead [...]

Bioarray Genetics Presents at the 40th Annual San Antonio Breast Cancer Symposium2018-04-26T20:57:56+00:00

Bioarray Genetics Series B Financing

2018-04-26T20:52:13+00:00

Bioarray Genetics Receives $4M in Series B Equity Financing Bioarray Genetics, a personalized medicine startup, announced today that it has received $4 million in Series B Equity Financing from Quark Venture and GF Securities through their Global Health Science Fund and Connecticut Innovations. Bioarray, a personalized medicine [...]

Bioarray Genetics Series B Financing2018-04-26T20:52:13+00:00

AACR Abstract: A novel panel of 325 biomarkers is part of a large interconnected network representing multiple cell signaling pathways and allowing development of predictive tests for oncology drugs

2018-04-20T05:30:58+00:00

A novel panel of 325 biomarkers is part of a large interconnected network representing multiple cell signaling pathways and allowing development of predictive tests for oncology drugs We developed an algorithm based on the gene expression of tumor biopsies to identify the best combination of biomarkers to reliably predict a [...]

AACR Abstract: A novel panel of 325 biomarkers is part of a large interconnected network representing multiple cell signaling pathways and allowing development of predictive tests for oncology drugs2018-04-20T05:30:58+00:00

AACR Abstract: Technical validation of novel 325 RNA predictive biomarkers using gene expression data generated by Nanostring n-counter and Affymetrix microarray

2018-04-25T03:51:08+00:00

Technical validation of novel 325 RNA predictive biomarkers using gene expression data generated by Nanostring n-counter and Affymetrix microarray With new developments of oncology drug combinations and targeted treatments, the ability to stratify categories of patient populations and to develop companion diagnostics has become increasingly important. A panel of 325 [...]

AACR Abstract: Technical validation of novel 325 RNA predictive biomarkers using gene expression data generated by Nanostring n-counter and Affymetrix microarray2018-04-25T03:51:08+00:00

BIOARRAY Genetics Inc. Announces the Launch of a Novel Oncology Gene Panel

2018-04-26T20:49:36+00:00

BIOARRAY Genetics Inc. Announces the Launch of a Novel Oncology Gene Panel BIOARRAY Genetics Inc. announced the launch of a novel oncology gene panel, BA325, a research and development tool that accelerates drug discovery and development for cancer treatments by providing new information on cancer response to treatments. BA325 contains [...]

BIOARRAY Genetics Inc. Announces the Launch of a Novel Oncology Gene Panel2018-04-26T20:49:36+00:00